CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 28 enrolled
Drug / intervention
N Acetyl Cysteine +1 moredrug
Likely dose
N Acetyl Cysteine 1200mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00967005
NCT00967005Phase 2Completed
CompareCT.gov

N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers

University of Chicago·interventional·Posted Aug 27, 2009·Updated Mar 21, 2023

In Brief

A Phase 2 clinical trial evaluating N Acetyl Cysteine and Sugar Pill for Gambling and Tobacco Use Disorder. Completed, enrolled 28 participants across 2 sites.

Detailed Summary

The objective of this application is to examine whether, given its mechanism of action, the dietary supplement, N-acetyl cysteine (NAC) will reduce both tobacco use and pathological gamblers (PG) symptoms in nicotine dependent pathological gamblers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGambling, Tobacco Use Disorder
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA), University of Minnesota

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 27, 2009
Enrollment StartSep 1, 2009
Primary CompletionSep 1, 2012
Study CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 16.8 years ago

Interventions

N Acetyl Cysteinedrug

N-Acetyl Cysteine, 1200mg-3000mg each day for 24-weeks

Sugar Pillother

placebo control